Recruiting

Participant Support Community

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT07532954

Conditions

Neuroendocrine Cervical Cancer

Patient Support

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Questionnaire

Study Details

Brief summary:

To learn about the effects of a participant support community on illness perception, emotional well-being, and feelings of isolation among participants with NECC.

Conditions

Neuroendocrine Cervical Cancer

Patient Support

Study ID

NCT07532954

Start date

Apr 13, 2026

Status verified date

May, 2026

Completion date

Nov 1, 2028

Anticipated

Primary completion date

Nov 1, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Eligibility Criteria

  • Histologically confirmed NECC.
  • Aged 18 years or older.
  • English proficient.
  • Provision of signed and dated informed consent form.
  • Stated willingness to comply with all study procedures and availability for the duration of the study.
  • Access to necessary resources for participating in a technology-based intervention (i.e., computer, smartphone, internet access).

Exclusion Criteria None

Study Design

Enrollment

40 participants

Anticipated

Interventions and Outcome Measures

Arms

Focus Group

participants will take part in a focus group session to share their personal experiences

Interventions

Questionnaire

Demographic questionnaire

Primary outcome measure

  • Demographic questionnaire [ Time Frame: Through study completion; an average of 1 year ]

Central Contacts and Locations

Central contacts

Larissa Meyer, MD

Meyerlmeyer@mdanderson.org

Locations

MD Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77044

Contacts

Larissa Meyer, MD

713-745-0973lmeyer@mdanderson.org

Principal Investigator:

Larissa Meyer, MD

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

May 18, 2026

Last verified

May, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-05-18.